Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
A chief financial officer walks into a room full of HR and benefits leaders… what sounds like the start of a joke was my ...
“Studies show that activities requiring learning and memory – like dance – can stimulate neuroplasticity, the brain’s ability ...
From an R&D standpoint, we believe that this is an important confirmation of the performance of the PL-14 formulation using a rigorous quanttative permeation model. The data support continued ...
A new state law taking effect Jan. 1 will bar the use of EBT cards to buy sugary foods such as soda and candy and will ...
“Healthy communities start with access to reliable care, no matter where you live,” said Health and Human Services Secretary ...
Israel has revoked the licenses of more than three dozen humanitarian organizations, and now those groups are grappling with ...
How-To Geek on MSN
5 things I wish I knew when I first learned programming
When I was new to programming, I focused way too much on learning the syntax, especially the brackets, the semicolons, and ...
Oklahoma Chief Operating Officer David Ostrowe is no longer listed on the OMES website as one of the agency’s administrators, but he still holds his COO role in the governor’s Cabinet. Ostrowe was ...
The fight for jobs and working conditions in the refineries is inseparable from a struggle against a government of the ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback